Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 3, open-label trial of pneumococcal 13-valent CRM197 vaccine conjugate [Prevnar 13] in children aged 5-10 years who had previously been vaccinated for the prevention of pneumococcal disease with pneumococcal 7-valent CRM197 vaccine conjugate [Prevnar], and vaccine-naive children and adolescents aged 10-17 years

Trial Profile

Phase 3, open-label trial of pneumococcal 13-valent CRM197 vaccine conjugate [Prevnar 13] in children aged 5-10 years who had previously been vaccinated for the prevention of pneumococcal disease with pneumococcal 7-valent CRM197 vaccine conjugate [Prevnar], and vaccine-naive children and adolescents aged 10-17 years

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 12 Feb 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
  • Indications Pneumococcal infections
  • Focus Pharmacodynamics; Registrational
  • Most Recent Events

    • 14 Mar 2012 New trial record
    • 12 Mar 2012 Results published in a Pfizer media release and presented at the 8th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD).
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top